BioPharmX Corp Uncategorized Contracts & Agreements
19 Contracts & Agreements
- Amendment No. 2 to Asset Acquisition Agreement, dated August 20, 2023, by and among Timber Pharmaceuticals LLC, Patagonia Pharmaceuticals LLC, Johnathan Rome and Zachary Rome (Filed With SEC on August 21, 2023)
- Letter Agreement, dated July 27, 2022, between Timber Pharmaceuticals, Inc. and TardiMed Sciences LLC (Filed With SEC on August 2, 2022)
- Amendment No. 1 to the Asset Acquisition Agreement, dated July 20, 2022, by and among Timber Pharmaceuticals LLC, Patagonia, Jonathan Rome and Zachary Rome (Filed With SEC on July 26, 2022)
- Offer Letter, dated January 19, 2021, between the Company and Alan Mendelsohn, M.D (Filed With SEC on January 25, 2021)
- Offer Letter, dated March 31, 2020, between Joseph Lucchese and Timber Sub (Filed With SEC on May 22, 2020)
- Offer Letter, dated March 31, 2020, between Michael Derby and Timber Sub (Filed With SEC on May 22, 2020)
- Offer Letter, dated March 31, 2020, between Zachary Rome and Timber Sub (Filed With SEC on May 22, 2020)
- Asset Acquisition Agreement, dated June 26, 2019, by and among Timber, Patagonia, Jonathan Rome and Zachary Rome (Filed With SEC on February 20, 2020)
- Offer Letter, dated June 20, 2019, between John Koconis and Timber (Filed With SEC on February 20, 2020)
- Asset Acquisition Agreement, dated February 28, 2019, by and among Timber, Patagonia, Johnathan Rome and Zachary Rome (Filed With SEC on February 20, 2020)
- Form of Stockholder Support Agreement (Filed With SEC on January 29, 2020)
- Offer Letter between Steven Bosacki and the Company, effective as of July 16, 2019 (Filed With SEC on July 17, 2019)
- Offer Letter between David Tierney and the Company, effective as of September 11, 2018 (Filed With SEC on September 13, 2018)
- roth capital partners, llc 888 San Clemente Drive, Newport Beach, CA 92660 | 800 ###-###-#### | www.roth.com | Member SIPC/FINRA (Filed With SEC on April 26, 2017)
- BIOPHARMX CORPORATION 1098 Hamilton Court Menlo Park, California 94025 (Filed With SEC on August 18, 2016)
- STANDSTILL AGREEMENT (Filed With SEC on August 18, 2016)
- BIOPHARMX, INC. NOTICE OF INDUCEMENT OPTION GRANT (Filed With SEC on September 14, 2015)
- 1098 Hamilton Court Menlo Park, CA 94025 T: 650 ###-###-#### F: 650 ###-###-#### www.biopharmx.com (Filed With SEC on September 14, 2015)
- AMENDMENT AGREEMENT (Filed With SEC on January 27, 2014)